Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -66.59%11.35K | -10.18%4.08K | -29.15%11K | -19.95%90.08K | 68.32%36.03K | -1.13%33.98K | -83.86%4.54K | -45.76%15.53K | 112.52K | 21.4K |
| Selling and administrative expenses | -68.18%10.56K | -12.37%3.29K | -53.89%4K | -13.64%80.84K | 125.00%35.23K | 56.55%33.19K | -86.66%3.75K | -69.74%8.66K | --93.61K | --15.66K |
| -General and administrative expense | -68.18%10.56K | -12.37%3.29K | -53.89%4K | -13.64%80.84K | 125.00%35.23K | 56.55%33.19K | -86.66%3.75K | -69.74%8.66K | --93.61K | --15.66K |
| Other operating expenses | 0.00%791 | 0.25%791 | 2.07%7.01K | -51.15%9.24K | -86.19%793 | -93.99%791 | --789 | --6.87K | --18.91K | --5.74K |
| Operating profit | 66.59%-11.35K | 10.18%-4.08K | 29.15%-11K | 19.95%-90.08K | -68.32%-36.03K | 1.13%-33.98K | 83.86%-4.54K | 45.76%-15.53K | -112.52K | -21.4K |
| Net non-operating interest income (expenses) | ||||||||||
| Other net income (expenses) | ||||||||||
| Income before tax | 66.59%-11.35K | 10.18%-4.08K | 29.15%-11K | 19.95%-90.08K | -68.32%-36.03K | 1.13%-33.98K | 83.86%-4.54K | 45.76%-15.53K | -112.52K | -21.4K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 66.59%-11.35K | 10.18%-4.08K | 29.15%-11K | 19.95%-90.08K | -68.32%-36.03K | 1.13%-33.98K | 83.86%-4.54K | 45.76%-15.53K | -112.52K | -21.4K |
| Net income continuous operations | 66.59%-11.35K | 10.18%-4.08K | 29.15%-11K | 19.95%-90.08K | -68.32%-36.03K | 1.13%-33.98K | 83.86%-4.54K | 45.76%-15.53K | ---112.52K | ---21.4K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 66.59%-11.35K | 10.18%-4.08K | 29.15%-11K | 19.95%-90.08K | -68.32%-36.03K | 1.13%-33.98K | 83.86%-4.54K | 45.76%-15.53K | -112.52K | -21.4K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 66.59%-11.35K | 10.18%-4.08K | 29.15%-11K | 19.95%-90.08K | -68.32%-36.03K | 1.13%-33.98K | 83.86%-4.54K | 45.76%-15.53K | -112.52K | -21.4K |
| Diluted earnings per share | 0 | 0 | 0 | 50.00%-0.02 | -100.92%-0.01 | 50.00%-0.01 | 0 | 0 | -0.04 | -0.005 |
| Basic earnings per share | 0 | 0 | 0 | 50.00%-0.02 | -100.92%-0.01 | 50.00%-0.01 | 0 | 0 | -0.04 | -0.005 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.